Ondřej Havránek: Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in DLBCL

Górniak P, Polak A, Rams A, Kupcova K, Głodkowska-Mrówka E, Pilch Z, Miączyńska M, Nowis D, Gołąb J, Davis RE, Havranek O, Juszczyński P. Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL). Cell Death Dis. 2026 Feb 11;17(1):216. (IF 9.6, Q1)